1999 related articles for article (PubMed ID: 33934060)
1. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).
Tougeron D; Hentzien M; Seitz-Polski B; Bani-Sadr F; Bourhis J; Ducreux M; Gaujoux S; Gorphe P; Guiu B; Hoang-Xuan K; Huguet F; Lecomte T; Lièvre A; Louvet C; Maggiori L; Mansi L; Mariani P; Michel P; Servettaz A; Thariat J; Westeel V; Aparicio T; Blay JY; Bouché O; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Eur J Cancer; 2021 Jun; 150():232-239. PubMed ID: 33934060
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)].
Tougeron D; Seitz-Polski B; Hentzien M; Bani-Sadr F; Bourhis J; Ducreux M; Gaujoux S; Gorphe P; Guiu B; Hardy-Bessard AC; Hoang Xuan K; Huguet F; Lecomte T; Lièvre A; Louvet C; Maggiori L; Mariani P; Michel P; Servettaz A; Thariat J; Westeel V; Aparicio T; Blay JY; Bouché O; ; ; ; ; ; ; ; ; ; ; ; ; ;
Bull Cancer; 2021 Jun; 108(6):614-626. PubMed ID: 33902918
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 vaccines for cancer patients: a call to action.
Corti C; Crimini E; Tarantino P; Pravettoni G; Eggermont AMM; Delaloge S; Curigliano G
Eur J Cancer; 2021 May; 148():316-327. PubMed ID: 33770576
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit?
Laporte BEP; Laporte EGJ; Aarestrup PF; Aarestrup MF; Aarestrup FM
Rev Bras Ginecol Obstet; 2022 Jun; 44(6):602-608. PubMed ID: 35820424
[TBL] [Abstract][Full Text] [Related]
7. Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
Oberemok VV; Andreeva OA; Laikova KV; Novikov IA; Puzanova YV; Kubyshkin AV
Inflamm Res; 2022 Jun; 71(5-6):521-536. PubMed ID: 35397666
[TBL] [Abstract][Full Text] [Related]
8. Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology Registry.
Kurbegov D; Bruinooge SS; Lei XJ; Kirkwood MK; Dickson N; Hattiangadi T; Mileham KF; Patrick A; Williams JH; Kaltenbaugh M; Gralow JR; Garrett-Mayer E
Cancer; 2023 Jun; 129(11):1752-1762. PubMed ID: 36920457
[TBL] [Abstract][Full Text] [Related]
9. Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.
Gundavda MK; Gundavda KK
Curr Treat Options Oncol; 2021 Sep; 22(10):95. PubMed ID: 34515857
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.
Velikova T; Georgiev T
Rheumatol Int; 2021 Mar; 41(3):509-518. PubMed ID: 33515320
[TBL] [Abstract][Full Text] [Related]
11. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
12. Cross-protective immunity following coronavirus vaccination and coronavirus infection.
Dangi T; Palacio N; Sanchez S; Park M; Class J; Visvabharathy L; Ciucci T; Koralnik IJ; Richner JM; Penaloza-MacMaster P
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34623973
[TBL] [Abstract][Full Text] [Related]
13. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
Peeters M; Verbruggen L; Teuwen L; Vanhoutte G; Vande Kerckhove S; Peeters B; Raats S; Van der Massen I; De Keersmaecker S; Debie Y; Huizing M; Pannus P; Neven K; Ariën KK; Martens GA; Van Den Bulcke M; Roelant E; Desombere I; Anguille S; Goossens M; Vandamme T; van Dam P
ESMO Open; 2021 Oct; 6(5):100274. PubMed ID: 34597941
[TBL] [Abstract][Full Text] [Related]
14. Will vaccination refusal prolong the war on SARS-CoV-2?
Marcec R; Majta M; Likic R
Postgrad Med J; 2021 Mar; 97(1145):143-149. PubMed ID: 33115909
[TBL] [Abstract][Full Text] [Related]
15. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
[TBL] [Abstract][Full Text] [Related]
16. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
Tamura T; Ninomiya K; Kubo T; Kuyama S; Tachibana S; Inoue K; Chikamori K; Kudo K; Ochi N; Harada D; Maeda Y; Kiura K
Thorac Cancer; 2022 Feb; 13(3):453-459. PubMed ID: 34964270
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
18. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
[TBL] [Abstract][Full Text] [Related]
19. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
[TBL] [Abstract][Full Text] [Related]
20. How to think about severe acute respiratory syndrome coronavirus 2 vaccination for pregnant and lactating women in China.
Li P; Liu H; Zou Y; Fang M; Chen Y; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1386-1391. PubMed ID: 35232909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
